AU2006244197A1 - Cellular cardiomyoplasty as supportive therapy in patients with heart disease - Google Patents

Cellular cardiomyoplasty as supportive therapy in patients with heart disease Download PDF

Info

Publication number
AU2006244197A1
AU2006244197A1 AU2006244197A AU2006244197A AU2006244197A1 AU 2006244197 A1 AU2006244197 A1 AU 2006244197A1 AU 2006244197 A AU2006244197 A AU 2006244197A AU 2006244197 A AU2006244197 A AU 2006244197A AU 2006244197 A1 AU2006244197 A1 AU 2006244197A1
Authority
AU
Australia
Prior art keywords
patient
cells
treating
heart
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006244197A
Other languages
English (en)
Inventor
Jonathan H. Dinsmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mytogen Inc
Original Assignee
Mytogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mytogen Inc filed Critical Mytogen Inc
Publication of AU2006244197A1 publication Critical patent/AU2006244197A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2006244197A 2005-05-09 2006-05-09 Cellular cardiomyoplasty as supportive therapy in patients with heart disease Abandoned AU2006244197A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67897605P 2005-05-09 2005-05-09
US60/678,976 2005-05-09
PCT/US2006/017683 WO2006122005A2 (en) 2005-05-09 2006-05-09 Cellular cardiomyoplasty as supportive therapy in patients with heart disease

Publications (1)

Publication Number Publication Date
AU2006244197A1 true AU2006244197A1 (en) 2006-11-16

Family

ID=37397196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006244197A Abandoned AU2006244197A1 (en) 2005-05-09 2006-05-09 Cellular cardiomyoplasty as supportive therapy in patients with heart disease

Country Status (5)

Country Link
US (1) US8889122B2 (https=)
EP (1) EP1885185A4 (https=)
JP (1) JP2008540536A (https=)
AU (1) AU2006244197A1 (https=)
WO (1) WO2006122005A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9462960B2 (en) * 2003-02-21 2016-10-11 3Dt Holdings, Llc Impedance devices and methods of using the same to obtain luminal organ measurements
US8038595B2 (en) * 2006-01-25 2011-10-18 Beth Israel Deaconess Medical Center Devices and methods for tissue transplant and regeneration
RU2325843C1 (ru) * 2006-11-28 2008-06-10 Государственное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ определения критерия для проведения медикаментозной терапии и контроля за эффективностью лечения у больных безболевой ишемией миокарда
CN102869988B (zh) * 2010-08-17 2015-09-23 泰尔茂株式会社 移植片的评价方法
US20160000834A1 (en) * 2013-02-28 2016-01-07 Ventrix, Inc. Methods and compositions for tissue therapy and analysis
SG10201907918VA (en) 2015-03-23 2019-10-30 Astellas Inst For Regenerative Medicine Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors
US10398820B2 (en) 2016-02-12 2019-09-03 Mallinckrodt Hospital Products IP Limited Use and monitoring of inhaled nitric oxide with left ventricular assist devices
SG11202104756UA (en) * 2018-11-08 2021-06-29 Univ Miami Method of determining responsiveness to cell therapy in dilated cardiomyopathy

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5143842A (en) 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
JP3244696B2 (ja) 1989-06-13 2002-01-07 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー ヒト筋肉細胞の単離、増殖および分化
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
WO1991011522A1 (en) 1990-01-26 1991-08-08 Baylor College Of Medicine MUTATED PROMOTER REGION FROM CHICKEN SKELETAL α-ACTIN GENE
US5199942A (en) 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5543318A (en) 1991-06-12 1996-08-06 Smith; David A. Method of isolation, culture and proliferation of human atrial myocytes
EP0590066A4 (en) 1991-06-12 1994-12-07 David A Smith METHOD FOR INDUCING HUMAN MYOCARDIAL CELL PROLIFERATION.
US5405772A (en) 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
WO1995012979A1 (en) 1993-11-08 1995-05-18 The University Of Southern California Compositions and methods for transduction of cells
US6015671A (en) 1995-06-07 2000-01-18 Indiana University Foundation Myocardial grafts and cellular compositions
US5602301A (en) 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
US6239172B1 (en) 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
US5968983A (en) 1994-10-05 1999-10-19 Nitrosystems, Inc Method and formulation for treating vascular disease
SG99279A1 (en) 1994-12-13 2003-10-27 Peter K Law Myoblast therapy for cosmetic treatment
CA2217131A1 (en) 1995-04-20 1996-12-05 Diacrin, Incorporated Modified cells and methods for inhibiting xenograft rejection
US5919449A (en) 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
US5985653A (en) 1995-06-07 1999-11-16 Aastrom Biosciences, Inc. Incubator apparatus for use in a system for maintaining and growing biological cells
US6238908B1 (en) 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
US6228635B1 (en) 1995-06-07 2001-05-08 Aastrom Bioscience, Inc. Portable cell growth cassette for use in maintaining and growing biological cells
US6096532A (en) 1995-06-07 2000-08-01 Aastrom Biosciences, Inc. Processor apparatus for use in a system for maintaining and growing biological cells
CA2269096C (en) 1996-10-18 2009-12-15 Universite Laval Method for in vitro preconditioning of myoblasts before transplantation
CA2275436A1 (en) 1996-12-20 1998-07-02 Curis, Inc. Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
US6099832A (en) 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
US6110459A (en) 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
CA2225185A1 (en) 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
US5972013A (en) 1997-09-19 1999-10-26 Comedicus Incorporated Direct pericardial access device with deflecting mechanism and method
US6151525A (en) 1997-11-07 2000-11-21 Medtronic, Inc. Method and system for myocardial identifier repair
US6107034A (en) 1998-03-09 2000-08-22 The Board Of Trustees Of The Leland Stanford Junior University GATA-3 expression in human breast carcinoma
AU783935B2 (en) 1999-06-18 2006-01-05 Indiana University Research And Technology Corporation Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same
US20030113301A1 (en) 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
US6673604B1 (en) * 1999-07-23 2004-01-06 Diacrin, Inc. Muscle cells and their use in cardiac repair
EP1221956A2 (en) * 1999-09-30 2002-07-17 McGILL UNIVERSITY Autologous marrow stem cell (msc) transplantation for myocardial regeneration
WO2003006950A2 (en) 2001-07-12 2003-01-23 Geron Corporation Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
US20050244384A1 (en) 2002-04-01 2005-11-03 Law Peter K Cellular transplantation for heart regeneration
WO2004012791A2 (en) 2002-08-06 2004-02-12 Genvec, Inc. Improved injection system
US20060104961A1 (en) 2002-08-09 2006-05-18 Law Peter K Mechanisms of myoblast transfer in treating heart failure

Also Published As

Publication number Publication date
EP1885185A2 (en) 2008-02-13
EP1885185A4 (en) 2010-04-07
JP2008540536A (ja) 2008-11-20
US8889122B2 (en) 2014-11-18
WO2006122005A3 (en) 2007-11-01
WO2006122005A2 (en) 2006-11-16
US20060276685A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
Dib et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy
US20070059288A1 (en) Treatment for heart disease
Min et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs
López et al. Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report
Saito et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction
US20130041348A1 (en) Catheter-Based Delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
CN103221058B (zh) 用于心脏修复的骨髓衍生cd271前体细胞
US20040136966A1 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
Beliën et al. Combining stem cells in myocardial infarction: The road to superior repair?
Huang et al. A translational approach in using cell sheet fragments of autologous bone marrow-derived mesenchymal stem cells for cellular cardiomyoplasty in a porcine model
Enoki et al. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction
CN114224916B (zh) 用于治疗心力衰竭的方法
Haider et al. MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases
US8889122B2 (en) Cellular cardiomyoplasty as supportive therapy in patients with heart disease
JP2012516853A (ja) 分化した内皮前駆細胞の治療的使用
Premaratne et al. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction
Muqresh et al. Myogenic Cardiac Regeneration: Clinical Studies Using Skeletal Myoblasts
Dib et al. Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium
US20160287638A1 (en) Ischemic tolerant cells and cellular factors in the treatment of peripheral artery disease
Lancaster Development and testing of a tissue engineered cardiac construct for treatment of chronic heart failure
Rodrigo Intramyocardial bone marrow cell injection for ischemic heart disease: efficacy
Psaltis The Cardiovascular Reparative Properties of Bone Marrow Mesenchymal Precursor Cells
Noiseux et al. Autologous Stem Cells for Cardiac Repair: New Insights on Clinical Trial Safety and Best Cell Source
Ladage et al. Stimulating Myocardial Regeneration with Periostin Peptide in Large Mammals
Arom et al. SURGICAL AUTOLOGOUS PERIPHERAL BLOOD STEM CELL IMPLANTATION FOR CARDIOMYOPATHY: BANGKOK HEART HOSPITAL EXPERIENCE

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted